scholarly article | Q13442814 |
P2093 | author name string | Mario Tiberi | |
Annette Gower | |||
P2860 | cites work | Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2 | Q21134725 |
Abuse of amphetamines and structural abnormalities in the brain | Q22241673 | ||
Dopamine neuron systems in the brain: an update | Q22251429 | ||
Amphetamines for improving recovery after stroke | Q24246202 | ||
Dopamine D2 receptor activation leads to an up-regulation of glial cell line-derived neurotrophic factor via Gβγ-Erk1/2-dependent induction of Zif268 | Q24312888 | ||
CART peptides as modulators of dopamine and psychostimulants and interactions with the mesolimbic dopaminergic system | Q24606890 | ||
Amphetamine causes dopamine depletion and cell death in the mouse olfactory bulb | Q24650859 | ||
Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth | Q24656080 | ||
Potential adverse effects of amphetamine treatment on brain and behavior: a review | Q24657966 | ||
Methylphenidate Abuse and Psychiatric Side Effects | Q24683020 | ||
Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications | Q26752602 | ||
60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis | Q28087609 | ||
Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity | Q28185479 | ||
Dopamine receptors - IUPHAR Review 13 | Q28256783 | ||
CART peptides: regulators of body weight, reward and other functions | Q28294402 | ||
The physiology, signaling, and pharmacology of dopamine receptors | Q28305030 | ||
A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia | Q28307728 | ||
Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury | Q48909526 | ||
Characteristic changes in T(2)-value, apparent diffusion coefficient, and ultrastructure of substantia nigra evolving exofocal postischemic neuronal death in rats | Q48945702 | ||
'Real time' measurement of dopamine release in an in vitro model of neostriatal ischaemia | Q48949148 | ||
Gabaergic transmission and tyrosine hydroxylase expression in the nigral dopaminergic neurons: an in vivo study using a reversible ischemia model of rats | Q48955011 | ||
Acute but not delayed amphetamine treatment improves behavioral outcome in a rat embolic stroke model | Q49049534 | ||
Atrophy of the ipsilateral substantia nigra following middle cerebral artery occlusion in the rat. | Q49095234 | ||
Beam-walking in rats: studies towards developing an animal model of functional recovery after brain injury | Q49110375 | ||
Cocaine- and amphetamine-regulated transcript peptide (CART) alleviates MK-801 induced schizophrenic dementia-like symptoms | Q50096774 | ||
Effect of low dose levodopa on motor outcome of different types of stroke. | Q50993882 | ||
Dose-dependent nonlinear effect of L-DOPA on paired associative stimulation-induced neuroplasticity in humans. | Q51013779 | ||
Patterns and profiles of Methylphenidate use in both children and adults. | Q51411756 | ||
Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. | Q51991106 | ||
The effects of amphetamine on recovery of function after cortical damage in the rat depend on the behavioral requirements of the task. | Q52201200 | ||
Methylphenidate clinically oral doses improved brain and heart glutathione redox status and evoked renal and cardiac tissue injury in rats. | Q52684861 | ||
Histochemical study on neurodegeneration in the olfactory bulb after transient forebrain ischaemia in the Mongolian gerbil. | Q53891491 | ||
CREB controls cortical circuit plasticity and functional recovery after stroke. | Q55039386 | ||
Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists | Q46677579 | ||
Enhancing the Alignment of the Preclinical and Clinical Stroke Recovery Research Pipeline: Consensus-Based Core Recommendations From the Stroke Recovery and Rehabilitation Roundtable Translational Working Group | Q46711980 | ||
Levodopa improves skilled hand functions in the elderly | Q46724029 | ||
Modification of practice-dependent plasticity in human motor cortex by neuromodulators | Q46750165 | ||
Recovery of tactile placing after visual cortex ablation in cat: a behavioral and metabolic study of diaschisis | Q46761748 | ||
Amphetamine induces dendritic growth in ventral tegmental area dopaminergic neurons in vivo via basic fibroblast growth factor | Q46842987 | ||
Amphetamine and task-specific practice augment recovery of vibrissae-evoked forelimb placing after unilateral sensorimotor cortical injury in the rat. | Q46844166 | ||
Motor-skill learning-associated gene regulation in the striatum: effects of cocaine | Q46881179 | ||
Effect of experimental ischemia on neurotransmitter amines in the gerbil brain | Q28317347 | ||
Genetic variation in the human brain dopamine system influences motor learning and its modulation by L-Dopa | Q28486256 | ||
Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors | Q28507196 | ||
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors | Q28512698 | ||
Dopamine D1/D5 receptors gate the acquisition of novel information through hippocampal long-term potentiation and long-term depression | Q28574184 | ||
Dopaminergic projections from midbrain to primary motor cortex mediate motor skill learning | Q28579657 | ||
Dopaminergic therapy in aphasia | Q28655767 | ||
Phenomenology and epidemiology of impulsive-compulsive behaviours in Parkinson's disease, atypical Parkinsonian disorders and non-Parkinsonian populations | Q30238907 | ||
Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 | ||
Dopamine in motor cortex is necessary for skill learning and synaptic plasticity | Q30873734 | ||
Vascular parkinsonism--characteristics, pathogenesis and treatment | Q30940108 | ||
Stimulatory role of dopamine on fibroblast growth factor-2 expression in rat striatum. | Q31961779 | ||
Olanzapine attenuates brain damage after focal cerebral ischemia in vivo | Q33264034 | ||
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients | Q33574373 | ||
Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection | Q33694824 | ||
Stroke triggers nigrostriatal plasticity and increases alcohol consumption in rats. | Q33746834 | ||
Influence of cerebral embolism on brain monoamines | Q33755630 | ||
Cytoarchitectural changes in the olfactory bulb of Parkinson's disease patients | Q33917258 | ||
Cabergoline decreases alcohol drinking and seeking behaviors via glial cell line-derived neurotrophic factor. | Q33954437 | ||
Methylphenidate: its pharmacology and uses | Q33976864 | ||
D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses. | Q34063708 | ||
The DARS (Dopamine Augmented Rehabilitation in Stroke) trial: protocol for a randomised controlled trial of Co-careldopa treatment in addition to routine NHS occupational and physical therapy after stroke | Q34067590 | ||
Levodopa treatment improves functional recovery after experimental stroke | Q34077544 | ||
Amphetamine toxicities: classical and emerging mechanisms. | Q34102002 | ||
Dopaminergic control of synaptic plasticity in the dorsal striatum | Q34206258 | ||
The effects of amphetamine on recovery of function in animal models of cerebral injury: a critical appraisal | Q34207775 | ||
Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. | Q34372253 | ||
Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates | Q34433630 | ||
Motor-skill learning in a novel running-wheel task is dependent on D1 dopamine receptors in the striatum | Q34589454 | ||
Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke | Q34715397 | ||
Post-treatment with amphetamine enhances reinnervation of the ipsilateral side cortex in stroke rats | Q34759921 | ||
On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons? | Q34794235 | ||
The role of dopamine in cerebral ischemic damage: a review of studies with Gerald Cohen | Q34826213 | ||
Dopamine-enabled anti-Hebbian timing-dependent plasticity in prefrontal circuitry | Q37734837 | ||
Statistical analysis of the primary outcome in acute stroke trials | Q37994538 | ||
Interactions between NMDA and dopamine receptors: a potential therapeutic target. | Q37999605 | ||
Secondary neurodegeneration in remote regions after focal cerebral infarction: a new target for stroke management? | Q38001645 | ||
Abnormal striatal dopamine transmission in schizophrenia | Q38060250 | ||
Outcome measures in stroke rehabilitation. | Q38073403 | ||
Safety in pharmacological enhancement of stroke rehabilitation | Q38084412 | ||
Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management | Q38085546 | ||
Motor function-related maladaptive plasticity in stroke: a review | Q38093762 | ||
Role, indications and controversies of levodopa administration in chronic stroke patients | Q38096274 | ||
Prefrontal dopamine and behavioral flexibility: shifting from an "inverted-U" toward a family of functions | Q38102685 | ||
Promoting neuroplasticity for motor rehabilitation after stroke: considering the effects of aerobic exercise and genetic variation on brain-derived neurotrophic factor | Q38125896 | ||
Pharmacological therapies to enhance motor recovery and walking after stroke: emerging strategies | Q38130552 | ||
Post-stroke recovery: the role of activity-dependent release of brain-derived neurotrophic factor | Q38260556 | ||
Role of synaptic and nonsynaptic glutamate receptors in ischaemia induced neurotoxicity | Q38300716 | ||
Methamphetamine administration causes death of dopaminergic neurons in the mouse olfactory bulb | Q38306625 | ||
Levodopa improves procedural motor learning in chronic stroke patients | Q38387537 | ||
Biomarkers of stroke recovery: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable. | Q38659060 | ||
Genetic Variation and Neuroplasticity: Role in Rehabilitation After Stroke | Q38669324 | ||
Pharmacological Treatment of Visuospatial Neglect: A Systematic Review | Q38753311 | ||
Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons | Q38868116 | ||
A Review and Conceptual Model of Dopaminergic Contributions to Poststroke Depression. | Q38942333 | ||
Hyperdopaminergism in lenticulostriate stroke-related restless legs syndrome: an imaging study. | Q38953465 | ||
Dopamine Gene Profiling to Predict Impulse Control and Effects of Dopamine Agonist Ropinirole | Q39136481 | ||
Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update. | Q39147625 | ||
Exercise enhanced functional recovery and expression of GDNF after photochemically induced cerebral infarction in the rat. | Q39219420 | ||
Pharmacological therapies in post stroke recovery: recommendations for future clinical trials | Q39316641 | ||
Prolonged modulation of FGF-2 expression in astrocytic cultures induced by O,O'-diacetyl-apomorphine | Q39322913 | ||
Association between genetic variation in the dopamine system and motor recovery after stroke. | Q39334932 | ||
Neuroanatomic pathways associated with monoaminergic dysregulation after stroke. | Q39717355 | ||
Dexamphetamine improves upper extremity outcome during rehabilitation after stroke: a pilot randomized controlled trial | Q39734613 | ||
Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial | Q39736173 | ||
The effect of dopamine agonists: the expression of GDNF, NGF, and BDNF in cultured mouse astrocytes | Q39744247 | ||
Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke--a randomized, double-blind, placebo-controlled trial. | Q39861267 | ||
Post-treatment with cocaine- and amphetamine-regulated transcript enhances infarct resolution, reinnervation, and angiogenesis in stroke rats - an MRI study | Q39968198 | ||
Dopamine reverses reward insensitivity in apathy following globus pallidus lesions | Q40219321 | ||
Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats | Q40250561 | ||
Substantia nigra lesion protects against ischemic damage in the striatum | Q46884554 | ||
D-amphetamine improves cognitive deficits and physical therapy promotes fine motor rehabilitation in a rat embolic stroke model | Q46914958 | ||
Brain hemodynamic changes mediated by dopamine receptors: Role of the cerebral microvasculature in dopamine-mediated neurovascular coupling | Q46928600 | ||
Amphetamine fails to facilitate motor performance and to enhance motor recovery among stroke patients with mild arm paresis: interim analysis and termination of a double blind, randomised, placebo-controlled trial. | Q46943317 | ||
Influence of amphetamine on recovery after intracerebral hemorrhage in rats | Q46975565 | ||
BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. | Q47226339 | ||
The dopamine D1 but not D3 receptor plays a fundamental role in spatial working memory and BDNF expression in prefrontal cortex of mice | Q47404837 | ||
Rotigotine, a dopamine receptor agonist, increased BDNF protein levels in the rat cortex and hippocampus | Q47602170 | ||
Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies. | Q47648607 | ||
Evaluating rodent motor functions: Which tests to choose? | Q47650172 | ||
Effects of dopamine on the cerebral blood flow in the dog | Q47855680 | ||
Pharmacotherapy and motor recovery after stroke. | Q47975906 | ||
Role of dopamine on functional recovery in the contralateral hemisphere after focal stroke in the somatosensory cortex | Q47997085 | ||
Receptor alterations in subcortical structures after bilateral middle cerebral artery infarction of the cerebral cortex | Q48092180 | ||
No improvement by amphetamine on learned non-use, attempts, success or movement in skilled reaching by the rat after motor cortex stroke | Q48145047 | ||
Excitatory and inhibitory amino acid neurotransmitters in stroke: from neurotoxicity to ischemic tolerance. | Q48146077 | ||
Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. | Q48163949 | ||
Dopamine has inhibitory and accelerating effects on ischemia-induced neuronal cell damage in the rat striatum | Q48226089 | ||
Dopaminergic regulation of cerebral cortical microcirculation | Q48242744 | ||
Loss of substance P and inflammation precede delayed neurodegeneration in the substantia nigra after cerebral ischemia | Q48256864 | ||
Exposure to amphetamine after substantia nigra lesion interferes with the process of behavioral recovery | Q48272081 | ||
N-methyl-D-aspartate receptor type 1 immunoreactivity and protein level in the gerbil main olfactory bulb after transient forebrain ischemia | Q48341438 | ||
Age-specific transcriptional response to stroke. | Q48351254 | ||
Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats | Q48357199 | ||
A single injection of D-amphetamine facilitates improvements in motor training following a focal cortical infarct in squirrel monkeys | Q48379744 | ||
Methylphenidate modulates cerebral post-stroke reorganization | Q48420041 | ||
Axonal plasticity is associated with motor recovery following amphetamine treatment combined with rehabilitation after brain injury in the adult rat. | Q48442769 | ||
Ultrastructural and MRI study of the substantia nigra evolving exofocal post-ischemic neuronal death in the rat. | Q48454118 | ||
A shift of paradigm: from noradrenergic to dopaminergic modulation of learning? | Q48481475 | ||
Potential effects of common drugs on stroke recovery | Q48482996 | ||
Dopamine transporter genotype influences the physiological response to medication in ADHD. | Q48506374 | ||
Degeneration of the ipsilateral substantia nigra following cerebral infarction in the striatum | Q48518380 | ||
Risperidone attenuates brain damage after focal cerebral ischemia in vivo | Q48528126 | ||
D1 receptor modulation of memory retrieval performance is associated with changes in pCREB and pDARPP-32 in rat prefrontal cortex | Q48546755 | ||
Transfer of Function to a Specific Area of the Cortex After Induced Recovery from Brain Damage | Q48551982 | ||
d-Amphetamine attenuates decreased cerebral glucose utilization after unilateral sensorimotor cortex contusion in rats | Q48552271 | ||
Striatal silent lacunar infarction is associated with changes to the substantia nigra in patients with early-stage Parkinson's disease: A diffusion kurtosis imaging study | Q48583739 | ||
Reduction in brain dopamine following experimental cerebral ischaemia | Q48585069 | ||
Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression | Q48589594 | ||
Free radicals and neurotransmitters in gerbil brain. Influence of age and ischemia reperfusion insult | Q48592658 | ||
Dopaminergic modulation of long-lasting direct current-induced cortical excitability changes in the human motor cortex | Q48609041 | ||
Degeneration of the ipsilateral substantia nigra after striatal infarction: evaluation with MR imaging | Q48632063 | ||
Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. | Q48681399 | ||
Nerve terminal damage in cerebral ischemia: greater susceptibility of catecholamine nerve terminals relative to serotonin nerve terminals | Q48717179 | ||
Hydrogel-delivered brain-derived neurotrophic factor promotes tissue repair and recovery after stroke | Q48738767 | ||
Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats | Q48792323 | ||
Expression of basic fibroblast growth factor mRNA and protein in the human brain following ischaemic stroke | Q48795508 | ||
Amphetamine effects on long term potentiation in dentate granule cells | Q48808097 | ||
Amphetamine and apomorphine restore tactile placing after motor cortex injury in the cat. | Q48831552 | ||
Disorders of smell, taste, and food intake in a patient with a dorsomedial thalamic infarct | Q48849682 | ||
Movement disorders after stroke. | Q34960517 | ||
Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials | Q34972793 | ||
Speeding stroke recovery? A systematic review of amphetamine after stroke | Q34982137 | ||
Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine | Q35023131 | ||
Inverted-U-shaped dopamine actions on human working memory and cognitive control | Q35035569 | ||
Reversal of stroke induced lymphocytopenia by levodopa/benserazide treatment | Q35115869 | ||
Norepinephrine activates dopamine D4 receptors in the rat lateral habenula | Q35117597 | ||
Predominant D1 Receptors Involvement in the Over-expression of CART Peptides after Repeated Cocaine Administration | Q35127508 | ||
Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection | Q35131264 | ||
Reduction of rat brain CD8+ T-cells by levodopa/benserazide treatment after experimental stroke | Q35154574 | ||
Dexamphetamine treatment in stroke | Q35202489 | ||
Dynamics of major histocompatibility complex class II-positive cells in the postischemic brain--influence of levodopa treatment | Q35236218 | ||
Evidence for fibroblast growth factor-2 as a mediator of amphetamine-enhanced motor improvement following stroke | Q35258422 | ||
Dopamine Promotes Motor Cortex Plasticity and Motor Skill Learning via PLC Activation | Q35566814 | ||
Mechanisms by which dopamine receptors may influence synaptic plasticity | Q35611034 | ||
Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease | Q35683102 | ||
Dopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders | Q35795738 | ||
Olfactory dysfunction in chronic stroke patients | Q35803920 | ||
Levodopa combined with peripheral decarboxylase inhibition in Parkinson's disease | Q35926216 | ||
CNS dopamine transmission mediated by noradrenergic innervation | Q36020737 | ||
Protein Profile and Morphological Alterations in Penumbra after Focal Photothrombotic Infarction in the Rat Cerebral Cortex. | Q36057317 | ||
Olfaction in Parkinson's disease and related disorders | Q36193915 | ||
De novo expression of dopamine D2 receptors on microglia after stroke | Q36254342 | ||
Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease. | Q36364388 | ||
Amphetamine modulation of long‐term potentiation in the prefrontal cortex: dose dependency, monoaminergic contributions, and paradoxical rescue in hyperdopaminergic mutant | Q36464578 | ||
Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential | Q36562163 | ||
Dopamine D2-like receptors and the antidepressant response | Q36578274 | ||
CART peptide induces neuroregeneration in stroke rats | Q36587091 | ||
Diagnosis and treatment of impulse control disorders in patients with movement disorders | Q36761848 | ||
Dopamine-mediated regulation of corticostriatal synaptic plasticity. | Q36762821 | ||
Exercise and Environmental Enrichment as Enablers of Task-Specific Neuroplasticity and Stroke Recovery | Q36775222 | ||
Combining Dopaminergic Facilitation with Robot-Assisted Upper Limb Therapy in Stroke Survivors: A Focused Review | Q36900126 | ||
Noradrenergic pharmacotherapy, intracerebral infusion and adrenal transplantation promote functional recovery after cortical damage | Q36931683 | ||
Alleviation of brain injury-induced cerebral metabolic depression by amphetamine: a cytochrome oxidase histochemistry study | Q36931881 | ||
Recovery of function in humans: cortical stimulation and pharmacological treatments after stroke | Q36950700 | ||
Pharmacological enhancement of motor recovery in subacute and chronic stroke. | Q37115295 | ||
Effects of methylphenidate on motor system excitability in a response inhibition task | Q37140825 | ||
Anticipatory changes in regional cerebral hemodynamics: a new role for dopamine? | Q37221808 | ||
Motor recovery and axonal plasticity with short-term amphetamine after stroke | Q37249687 | ||
Sinomenine activates astrocytic dopamine D2 receptors and alleviates neuroinflammatory injury via the CRYAB/STAT3 pathway after ischemic stroke in mice | Q37326028 | ||
Amphetamine trials and tribulations | Q37344124 | ||
Dopamine overdose hypothesis: evidence and clinical implications | Q37384960 | ||
Locus coeruleus and dopaminergic consolidation of everyday memory | Q37510475 | ||
Dopamine release from the locus coeruleus to the dorsal hippocampus promotes spatial learning and memory | Q37534434 | ||
Motor recovery after stroke: a systematic review | Q37553377 | ||
Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke | Q37576016 | ||
Combination of transcranial direct current stimulation and methylphenidate in subacute stroke | Q56970904 | ||
Physiotherapy Coupled With Dextroamphetamine for Rehabilitation After Hemiparetic Stroke | Q57271995 | ||
Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients | Q59604031 | ||
Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo | Q60054612 | ||
Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity | Q63256021 | ||
Increase in extracellular dopamine in the striatum during cerebral ischemia: a study utilizing cerebral microdialysis | Q68371282 | ||
Striatal dopamine in acute cerebral ischemia of stroke-resistant rats | Q69048795 | ||
[Secondary degeneration of substantia nigra following massive basal ganglia infarction] | Q69447472 | ||
Amphetamine accelerates recovery of locomotor function following bilateral frontal cortex ablation in cats | Q69692159 | ||
Direct evidence of acute, massive striatal dopamine release in gerbils with unilateral strokes | Q69737917 | ||
Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis | Q69924743 | ||
Epinephrine and norepinephrine stimulation of adenylate cyclase in bovine retina homogenate: evidence for interaction with the dopamine D1 receptor | Q70135187 | ||
Pharmacokinetics of Levodopa | Q70331163 | ||
Histochemical changes of brain dopamine in an acute stage of cerebral ischemia in gerbils | Q70709682 | ||
Functional recovery of forelimb response capacity after forelimb primary motor cortex damage in the rat is due to the reorganization of adjacent areas of cortex | Q70940572 | ||
Monoamines and related enzymes in cerebral cortex and basal ganglia following transient ischemia in gerbils | Q71384415 | ||
Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence | Q71568505 | ||
Striatal dopamine-mediated motor behavior is altered following occlusion of the middle cerebral artery | Q71592189 | ||
Common drugs may influence motor recovery after stroke. The Sygen In Acute Stroke Study Investigators | Q72227410 | ||
Integrity of the mesocortical dopaminergic system is necessary for complete expression of in vivo hippocampal-prefrontal cortex long-term potentiation | Q73333020 | ||
Regionally distinct regulation of astroglial neurotransmitter receptors by fibroblast growth factor-2 | Q73959400 | ||
Striatal infarction in the rat causes a transient reduction of tyrosine hydroxylase immunoreactivity in the ipsilateral substantia nigra | Q74080621 | ||
Plasticity of the human motor cortex and recovery from stroke | Q77110218 | ||
Norepinephrine acts as D1-dopaminergic agonist in the embryonic avian retina: late expression of beta1-adrenergic receptor shifts norepinephrine specificity in the adult tissue | Q79172671 | ||
Effects of amphetamine and/or L-dopa and physiotherapy after stroke - a blinded randomized study | Q79420196 | ||
No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study | Q80860624 | ||
Olfactory and taste dysfunction after bilateral middle cerebral artery stroke | Q81351850 | ||
Righting and other postural activity in low-decerebrate and in spinal cats after d-amphetamine | Q82184177 | ||
Combination treatment of low-frequency rTMS and occupational therapy with levodopa administration: an intensive neurorehabilitative approach for upper limb hemiparesis after stroke | Q83679693 | ||
Post-lesion practice and amphetamine-facilitated recovery of beam-walking in the rat | Q84062954 | ||
Adverse effects of catecholaminergic drugs following unilateral cerebellar ablations | Q84063272 | ||
Influence of lesion size and location on amphetamine-facilitated recovery of beam-walking in rats | Q95810782 | ||
Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons | Q40288241 | ||
Catecholamines in Experimental Brain Ischemia | Q40307977 | ||
Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons | Q40347833 | ||
Dopamine Regulation of Transcription Factor-Target Interactions in Rat Striatum | Q40427641 | ||
A dopamine D4 receptor antagonist attenuates ischemia-induced neuronal cell damage via upregulation of neuronal apoptosis inhibitory protein. | Q40454849 | ||
Cabergoline stimulates synthesis and secretion of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor by mouse astrocytes in primary culture | Q40551963 | ||
Safety of dexamphetamine in acute ischemic stroke: a randomized, double-blind, controlled dose-escalation trial | Q40606299 | ||
Activation of nuclear Ca(2+)/calmodulin-dependent protein kinase II and brain-derived neurotrophic factor gene expression by stimulation of dopamine D2 receptor in transfected NG108-15 cells | Q40717517 | ||
Absence of the dopamine D2 receptor leads to a decreased expression of GDNF and NT-4 mRNAs in restricted brain areas | Q40963111 | ||
Neurochemical specificity of learning: dopamine and motor learning. | Q41249296 | ||
In vivo imaging of dopaminergic neurotransmission after transient focal ischemia in rats | Q41834438 | ||
MRI heralds secondary nigral lesion after brain ischemia in mice: a secondary time window for neuroprotection. | Q41848302 | ||
Dynamic regulation of fibroblast growth factor 2 (FGF-2) gene expression in the rat brain following single and repeated cocaine administration. | Q42164678 | ||
Reaction of the substantia nigra to massive basal ganglia infarction | Q42461129 | ||
Effects of transient forebrain ischemia and reperfusion on function of dopaminergic neurons and dopamine reuptake in vivo in rat striatum | Q42469664 | ||
Extracellular dopamine and serotonin in the rat striatum during transient ischaemia of different severities: a microdialysis study | Q42509327 | ||
Trafermin for stroke recovery: is it time for another randomized clinical trial? | Q42614796 | ||
Safety of pharmacological augmentation of stroke rehabilitation. | Q42821364 | ||
Activation of Dopamine D2 Receptor Suppresses Neuroinflammation Through αB-Crystalline by Inhibition of NF-κB Nuclear Translocation in Experimental ICH Mice Model. | Q42875447 | ||
Effect of focal cerebral ischaemia on modulatory neurotransmitter receptors in the rat brain: an autoradiographic study | Q42987592 | ||
Poststroke treatment: lost in translation. | Q43081674 | ||
Successful treatment of post-stroke apathy by the dopamine receptor agonist ropinirole | Q43105788 | ||
Long-term levodopa administration in chronic stroke patients. A clinical and neurophysiologic single-blind placebo-controlled cross-over pilot study | Q43279475 | ||
Dopamine regulates brain-derived neurotrophic factor (BDNF) expression in cultured embryonic mouse striatal cells | Q43598295 | ||
Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study | Q43743049 | ||
A double-blind placebo-controlled study of the effects of amphetamine and physiotherapy after stroke | Q43771634 | ||
Failed attempts at intranasal abuse of Concerta | Q43859934 | ||
Interaction of BDNF and COMT polymorphisms on paired-associative stimulation-induced cortical plasticity. | Q44013749 | ||
Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury | Q44173703 | ||
CART protects brain from damage through ERK activation in ischemic stroke | Q44301884 | ||
Topography of cocaine-induced gene regulation in the rat striatum: relationship to cortical inputs and role of behavioural context | Q44373754 | ||
No benefit from D-amphetamine when added to physiotherapy after stroke: a randomized, placebo-controlled study | Q44583146 | ||
Dopaminergic D2 receptor activation modulates FGF-2 gene expression in rat prefrontal cortex and hippocampus | Q44586807 | ||
Effect of basic fibroblast growth factor treatment on brain progenitor cells after permanent focal ischemia in rats | Q44630482 | ||
Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia | Q44807649 | ||
Discrepancy between cell injury and benzodiazepine receptor binding after transient middle cerebral artery occlusion in rats | Q44987918 | ||
Motor skill learning depends on protein synthesis in motor cortex after training. | Q44989776 | ||
A case of abulia, status/post right middle cerebral artery territory infarct, treated successfully with olanzapine | Q45005420 | ||
Effects of monoaminergic drugs on training-induced motor cortex plasticity in older adults | Q45061758 | ||
Motor response to amphetamine treatment, task-specific training, and limited motor experience in a postacute animal stroke model | Q45097875 | ||
D1 but not D2 dopamine receptors or adrenoceptors mediate dopamine-induced potentiation of N-methyl-d-aspartate currents in the rat prefrontal cortex. | Q45142500 | ||
Randomized, placebo-controlled, double-blind study of ropinirole in chronic stroke | Q45274960 | ||
Activation of phosphatidylinositol-linked D1-like receptor modulates FGF-2 expression in astrocytes via IP3-dependent Ca2+ signaling. | Q45964940 | ||
Catechol-O-methyltransferase polymorphism influences outcome after ischemic stroke: a prospective double-blind study. | Q45975306 | ||
Risk of stroke in patients with idiopathic Parkinson disease | Q46072280 | ||
CREB at the Crossroads of Activity-Dependent Regulation of Nervous System Development and Function | Q46072299 | ||
D1-receptor impact on neuroplasticity in humans | Q46108360 | ||
Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine | Q46217278 | ||
Dopamine transporter genotype and methylphenidate dose response in children with ADHD. | Q46435466 | ||
D-amphetamine enhances skilled reaching after ischemic cortical lesions in rats | Q46464951 | ||
Anxious and hyperactive phenotype following brief ischemic episodes in mice | Q46468429 | ||
Modulation of recognition and temporal order memory retrieval by dopamine D1 receptor in rats | Q46537384 | ||
Secondary degeneration of the substantia nigra and corticospinal tract after hemorrhagic middle cerebral artery infarction: diffusion-weighted MR findings | Q46636130 | ||
Dopaminergic effects on encoding of a motor memory in chronic stroke | Q46641073 | ||
Amphetamine promotes task-dependent recovery following focal cortical ischaemic lesions in the rat. | Q46654812 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dopamine | Q170304 |
cell biology | Q7141 | ||
P304 | page(s) | 18 | |
P577 | publication date | 2018-01-01 | |
P1433 | published in | Frontiers in synaptic neuroscience | Q27723479 |
P1476 | title | The Intersection of Central Dopamine System and Stroke: Potential Avenues Aiming at Enhancement of Motor Recovery | |
P478 | volume | 10 |
Q92510341 | Bone Marrow Stromal Cells Alleviate Secondary Damage in the Substantia Nigra After Focal Cerebral Infarction in Rats |
Q91946240 | Methods for an Investigation of Neurophysiological and Kinematic Predictors of Response to Upper Extremity Repetitive Task Practice in Chronic Stroke |
Q92535648 | Neuroprotective Effects of Salidroside on Cerebral Ischemia/Reperfusion-Induced Behavioral Impairment Involves the Dopaminergic System |